Brief: Xspray: Rights Issue Oversubscribed, Over-Allotment Issue Increased And Fully Utilized
Sept 11 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST: XSPRAY’S RIGHTS ISSUE OVERSUBSCRIBED – OVER-ALLOTMENT ISSUE INCREASED AND FULLY UTILIZED TO INCREASE OVER-ALLOTMENT ISSUE TO APPROXIMATELY SEK 31 MILLION AND TO UTILIZE OVER-ALLOTMENT ISSUE WILL RECEIVE TOTAL ISSUE PROCEEDS OF APPROXIMATELY SEK 161 MILLION BEFORE DEDUCTION OF TRANSACTION COSTS Source text: ID:nMFN8nXQsG Further company coverage: XSPRAY.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003